Storia della carriera di Mark Chadwick
Precedenti posizioni note di Mark Chadwick
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Amsterdam Molecular Therapeutics (AMT) Holding NV
 Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Consigliere Generale | 23/06/2010 | 11/03/2013 |
J.A. Kemp LLP
 J.A. Kemp LLP Miscellaneous Commercial ServicesCommercial Services J.A. Kemp & Co. provides protection for patents, trade marks and intellectual property, under International, European and UK law. The company also provides legal advice in the areas of biotechnology, chemistry, electronics and engineering, patent assignments and trade marks. It has offices in the United Kingdom and Germany. The company is headquartered in London, UK. | Consigliere Generale | - | - |
Formazione di Mark Chadwick
| University of Cambridge | Undergraduate Degree |
| University of East Anglia | Doctorate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 4 |
| Paesi Bassi | 2 |
Posizioni
| General Counsel | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Commercial Services | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Commercial Services |
J.A. Kemp LLP
J.A. Kemp LLP Miscellaneous Commercial ServicesCommercial Services J.A. Kemp & Co. provides protection for patents, trade marks and intellectual property, under International, European and UK law. The company also provides legal advice in the areas of biotechnology, chemistry, electronics and engineering, patent assignments and trade marks. It has offices in the United Kingdom and Germany. The company is headquartered in London, UK. | Commercial Services |
- Borsa valori
- Insiders
- Mark Chadwick
- Esperienza
